Study Evaluating rFIX; BeneFIX® in Hemophilia B

NCT00093171 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

23

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemophilia B

Interventions

DRUG: rFIX

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer